Scott Braunstein - Mar 27, 2024 Form 4 Insider Report for MARINUS PHARMACEUTICALS, INC. (MRNS)

Role
CHAIRMAN AND CEO, Director
Signature
/s/ Debra A. Mohollen, Attorney-in-Fact
Stock symbol
MRNS
Transactions as of
Mar 27, 2024
Transactions value $
$214,000
Form type
4
Date filed
3/27/2024, 11:55 AM
Previous filing
Feb 22, 2024
Next filing
Jun 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNS Common Stock Options Exercise $214K +50K +22.37% $4.28 274K Mar 27, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNS Stock Option (Right to Buy) Options Exercise $0 -50K -20% $0.00 200K Mar 27, 2024 Common Stock 50K $4.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option, representing a right to purchase a total of 250,000 shares of common stock, vested and became exercisable in 48 substantially equal monthly installments beginning on September 6, 2019.